Surgical Resection is Justifiable for Oral T4b Squamous Cell Cancers With Masticator Space Invasion

To examine survival endpoints in patients with tumor (T)4b oral cavity squamous cell carcinoma (OCSCC) with pathologically proven masticator space invasion treated with primary surgery followed by adjuvant therapy. Retrospective review at an academic cancer center. Twenty-five patients with T4b OCSC...

Full description

Saved in:
Bibliographic Details
Published inThe Laryngoscope Vol. 131; no. 2; p. E466
Main Authors Baddour, H Michael, Ochsner, Matthew C, Patel, Mihir R, Switchenko, Jeffrey M, Beitler, Jonathan J, Magliocca, Kelly, Baugnon, Kristen L, Solares, Clementino A, Steuer, Conor E, El-Deiry, Mark W
Format Journal Article
LanguageEnglish
Published United States 01.02.2021
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To examine survival endpoints in patients with tumor (T)4b oral cavity squamous cell carcinoma (OCSCC) with pathologically proven masticator space invasion treated with primary surgery followed by adjuvant therapy. Retrospective review at an academic cancer center. Twenty-five patients with T4b OCSCC with pathologic masticator space invasion were treated with primary surgery from May 2012 to December 2016. Only patients with ≥ 2 years follow-up from date of surgery were included. Sixteen patients received adjuvant chemoradiation. Median follow-up time was 39 months from date of surgery. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival at 24 months were 44.0%, 63.2%, and 52.6%, respectively. On univariate analyses, adjuvant chemoradiation was associated with improved OS. Advanced age and prolonged length of hospital stay was associated with worse OS. For pT4b OCSCCA involving the masticator space, primary surgical resection followed by adjuvant chemoradiation demonstrates 24-month DSS of > 50% and OS of 44%. 4 Laryngoscope, 131:E466-E472, 2021.
AbstractList To examine survival endpoints in patients with tumor (T)4b oral cavity squamous cell carcinoma (OCSCC) with pathologically proven masticator space invasion treated with primary surgery followed by adjuvant therapy. Retrospective review at an academic cancer center. Twenty-five patients with T4b OCSCC with pathologic masticator space invasion were treated with primary surgery from May 2012 to December 2016. Only patients with ≥ 2 years follow-up from date of surgery were included. Sixteen patients received adjuvant chemoradiation. Median follow-up time was 39 months from date of surgery. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival at 24 months were 44.0%, 63.2%, and 52.6%, respectively. On univariate analyses, adjuvant chemoradiation was associated with improved OS. Advanced age and prolonged length of hospital stay was associated with worse OS. For pT4b OCSCCA involving the masticator space, primary surgical resection followed by adjuvant chemoradiation demonstrates 24-month DSS of > 50% and OS of 44%. 4 Laryngoscope, 131:E466-E472, 2021.
Author Patel, Mihir R
Magliocca, Kelly
Solares, Clementino A
Baugnon, Kristen L
Steuer, Conor E
Beitler, Jonathan J
Switchenko, Jeffrey M
El-Deiry, Mark W
Baddour, H Michael
Ochsner, Matthew C
Author_xml – sequence: 1
  givenname: H Michael
  surname: Baddour
  fullname: Baddour, H Michael
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia, U.S.A
– sequence: 2
  givenname: Matthew C
  orcidid: 0000-0002-7909-7751
  surname: Ochsner
  fullname: Ochsner, Matthew C
  organization: Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, U.S.A
– sequence: 3
  givenname: Mihir R
  orcidid: 0000-0001-6477-9728
  surname: Patel
  fullname: Patel, Mihir R
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia, U.S.A
– sequence: 4
  givenname: Jeffrey M
  surname: Switchenko
  fullname: Switchenko, Jeffrey M
  organization: Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, U.S.A
– sequence: 5
  givenname: Jonathan J
  surname: Beitler
  fullname: Beitler, Jonathan J
  organization: Department of Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, U.S.A
– sequence: 6
  givenname: Kelly
  surname: Magliocca
  fullname: Magliocca, Kelly
  organization: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, U.S.A
– sequence: 7
  givenname: Kristen L
  surname: Baugnon
  fullname: Baugnon, Kristen L
  organization: Department of Radiology and Imaging Services, Emory University School of Medicine, Atlanta, Georgia, U.S.A
– sequence: 8
  givenname: Clementino A
  surname: Solares
  fullname: Solares, Clementino A
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia, U.S.A
– sequence: 9
  givenname: Conor E
  surname: Steuer
  fullname: Steuer, Conor E
  organization: Department of Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, U.S.A
– sequence: 10
  givenname: Mark W
  surname: El-Deiry
  fullname: El-Deiry, Mark W
  organization: Winship Cancer Institute of Emory University, Atlanta, Georgia, U.S.A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32460370$$D View this record in MEDLINE/PubMed
BookMark eNo1kM1Kw0AUhQdRbK1ufACZF0i985fMLCX4U6kUbMVluZne0ZE0qZlE8O0NqKuz-c4H55yx46ZtiLFLAXMBIK9r7L7n0hbSHLGpMEpk2jkzYWcpfQCIQhk4ZRMldQ6qgCnz66F7ix5r_kyJfB_bhsfEH4fUxxCxqomHtuOrbiQ2uuLrzwH37ZB4SXXNS2w8dYm_xv6dP-HY8diP-PqAnvii-cI0Cs_ZScA60cVfztjL3e2mfMiWq_tFebPMvNbWZM45bQC9FiRyRFlUIAXurJEOKAjtVbDK5CLoICu0xgCYnSZFhXaFza2csatf72Go9rTbHrq4H-_Y_q-VP5AmVV0
CitedBy_id crossref_primary_10_1016_j_clon_2023_06_003
crossref_primary_10_1016_j_ijom_2022_04_015
crossref_primary_10_1007_s12325_024_02861_6
crossref_primary_10_1002_ohn_686
crossref_primary_10_1177_0194599820984358
crossref_primary_10_1016_j_ejso_2021_12_012
crossref_primary_10_1016_j_oraloncology_2021_105371
crossref_primary_10_1097_MD_0000000000029285
crossref_primary_10_1002_hed_26943
crossref_primary_10_1007_s40487_023_00246_3
crossref_primary_10_1016_j_oraloncology_2022_105750
crossref_primary_10_1097_MOO_0000000000000958
crossref_primary_10_1007_s12070_022_03404_7
ContentType Journal Article
Copyright 2020 The American Laryngological, Rhinological and Otological Society, Inc.
Copyright_xml – notice: 2020 The American Laryngological, Rhinological and Otological Society, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/lary.28725
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1531-4995
ExternalDocumentID 32460370
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA138292
GroupedDBID ---
--Z
.55
.GJ
05W
08G
08P
0R~
123
1L6
1OB
1OC
31~
33P
354
3WU
4.4
4Q1
4Q2
4Q3
53G
5RE
8-1
85S
8UM
A00
AAESR
AAHHS
AAKAS
AANLZ
AAONW
AAQQT
AASGY
AAWTL
AAXRX
AAZKR
ABCUV
ABJNI
ABOCM
ABPPZ
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBIZ
ADBTR
ADEOM
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AE3
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFTRI
AFUWQ
AFZJQ
AHBTC
AHMBA
AHRYX
AIACR
AITYG
AIURR
AIWBW
AIZYK
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
AVWKF
AZBYB
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BRXPI
CGR
CS3
CUY
CVF
DCZOG
DRFUL
DRMAN
DRSTM
DUUFO
EBS
ECM
EIF
EJD
EMOBN
EX3
F5P
FEDTE
FUBAC
G-S
GODZA
H0~
HGLYW
HVGLF
HZ~
H~9
IH2
J5H
JF9
JG8
KBYEO
KMI
L7B
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
M18
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N4W
NNB
NPM
NTWIH
O66
O9-
OAG
OAH
OHT
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OVD
OWU
OWV
OWW
OWX
OWY
OWZ
P-K
P2P
P2W
P4E
PALCI
PQQKQ
QRW
RIWAO
RJQFR
ROL
RWI
SAMSI
SUPJJ
T8P
TEORI
TN5
UHB
V9Y
VVN
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WUP
WVDHM
WXSBR
WYJ
X7M
XOL
XV2
XXN
XYM
YFH
YOC
YQY
ZFV
ZGI
ZXP
ZZTAW
~S-
ID FETCH-LOGICAL-c4485-999450ac41e16aa27b021ad85290ef14c3f83561f4f2ba855005d4e3e74978682
IngestDate Tue Aug 27 13:47:47 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords T4b tumor
masticator space
oral cancer
Oral cavity squamous cell carcinoma
Language English
License 2020 The American Laryngological, Rhinological and Otological Society, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4485-999450ac41e16aa27b021ad85290ef14c3f83561f4f2ba855005d4e3e74978682
ORCID 0000-0002-7909-7751
0000-0001-6477-9728
OpenAccessLink https://europepmc.org/articles/pmc7704866?pdf=render
PMID 32460370
ParticipantIDs pubmed_primary_32460370
PublicationCentury 2000
PublicationDate February 2021
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: February 2021
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Laryngoscope
PublicationTitleAlternate Laryngoscope
PublicationYear 2021
SSID ssj0017350
Score 2.459316
Snippet To examine survival endpoints in patients with tumor (T)4b oral cavity squamous cell carcinoma (OCSCC) with pathologically proven masticator space invasion...
SourceID pubmed
SourceType Index Database
StartPage E466
SubjectTerms Adult
Aged
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Female
Humans
Kaplan-Meier Estimate
Male
Masticatory Muscles - pathology
Middle Aged
Mouth Neoplasms - mortality
Mouth Neoplasms - pathology
Mouth Neoplasms - surgery
Neoplasm Invasiveness
Neoplasm Staging
Retrospective Studies
Survival Analysis
Title Surgical Resection is Justifiable for Oral T4b Squamous Cell Cancers With Masticator Space Invasion
URI https://www.ncbi.nlm.nih.gov/pubmed/32460370
Volume 131
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS9xAFB7WCuKLtN6qbWUefFuiuczk8liWLUvp2sIq-CaTycSNtVm7F0v7F_qne85cNqm2or6EkCEh5Ptycr6TcyHkMOSpDIMo8YqSxR5LksDLwRR74BmoqOCl5FooDk_iwRn7eM7PO53fraylxTw_kr_-WVfyHFThGOCKVbJPQHZ5UTgA-4AvbAFh2D4K49FiagwX5s-Zmd_VzAzoKitdE4VJhJ91DT7Lu6PvC4FKv9vDgF0P8Z5i_ut83B0K7NeMArw7AhWNCZW3YuYwu2oo9UlMf9aXE13M0kRBiwJuV3_F_srDx-CtHM9sTY0dLd7EZb-An3ttcvfH1bRJXRz9qJBL9ddJq9bMhm1tgCIMXE4zfl-cUQWdmplhmkura41_1VK_xob2mZnDcs-4m2ax1xiJBZ1n6qVbKN980zCDhxj7kZlG8vDqnUbbbmmFrCQpGssTDPzYH1JJxP1ld9vwuLmJdbLmTryjTLSHcvqSbFhpQd8bnrwiHVVvkrWhTZ7YItLRhS7pQqsZbdGFAl0o0oUCXaijC0W6UEsXinShDV2opgt1dNkmZx_6p72BZ2dseBKEOfdAHzDuC8kCFcRChEkOCIoi5WHmqzJgMirBR4-DkpVhLrD7nc8LpiKV4GjCOA13yIt6UqvXhEqFzUYLHy6SgRPuizgNpJ8IHANbZJnaI7vm8VzcmEYqF-7B7f935Q1Zbyj1lqyW8Oaqd-AGzvMDDdAfndZdBQ
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surgical+Resection+is+Justifiable+for+Oral+T4b+Squamous+Cell+Cancers+With+Masticator+Space+Invasion&rft.jtitle=The+Laryngoscope&rft.au=Baddour%2C+H+Michael&rft.au=Ochsner%2C+Matthew+C&rft.au=Patel%2C+Mihir+R&rft.au=Switchenko%2C+Jeffrey+M&rft.date=2021-02-01&rft.eissn=1531-4995&rft.volume=131&rft.issue=2&rft.spage=E466&rft_id=info:doi/10.1002%2Flary.28725&rft_id=info%3Apmid%2F32460370&rft_id=info%3Apmid%2F32460370&rft.externalDocID=32460370